Medicare Enrolled
Dr. Arkadiy Yadgarov
Ophthalmology · Atlanta, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Yadgarov from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Yadgarov?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Yadgarov
Dr. Arkadiy Yadgarov is an ophthalmology specialist in Atlanta, GA, with 14 years of NPI registration. Based on federal Medicare data, Dr. Yadgarov performed 5,333 Medicare services across 3,808 unique beneficiaries.
Between the years covered by Open Payments, Dr. Yadgarov received a total of $495,755 from 36 pharmaceutical and/or device companies across 1172 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Yadgarov is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years in practice
▲ Top 14% volume in GA
$495,755 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,333
Medicare services
Top 14% in GA for ophthalmology
3,808
Unique beneficiaries
$105
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~381 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Optic nerve imaging (OCT scan) Imaging of the optic nerve. |
772 | $24 | $200 |
| Injection, bimatoprost, intracameral implant, 1 microgram | 700 | $157 | $210 |
| Visual field test, extended A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam. |
534 | $45 | $145 |
| Extended exam of back of eye with optic nerve drawing A detailed examination of the posterior section of the eye, including the optic nerve, with documentation through drawing. |
448 | $11 | $48 |
| Comprehensive eye exam, established patient A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider. |
424 | $81 | $180 |
| Corneal topography and eye depth measurement This procedure measures the curvature and depth of the cornea, the clear front surface of the eye. |
396 | $28 | $208 |
| Eye exam, established patient, focused A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom. |
394 | $58 | $125 |
| Comprehensive eye exam, new patient A comprehensive examination of the visual system performed for a new patient. |
312 | $96 | $215 |
| Cataract surgery with lens implant Surgical removal of the clouded natural lens of the eye and replacement with an artificial prosthetic lens to restore vision. |
266 | $286 | $2,955 |
| Ultrasound scan of cornea to determine thickness An ultrasound procedure used to measure the thickness of the cornea. |
225 | $8 | $98 |
| Eye drainage system examination An examination of the internal drainage system of the eye to assess how fluid flows and drains from the eye. |
222 | $20 | $64 |
| Incision to improve eye fluid flow A surgical procedure involving an incision to enhance the drainage of fluid within the eye. |
165 | $633 | $2,400 |
| Laser removal of recurring cataract A laser procedure to remove a recurring cataract within the lens capsule. |
109 | $310 | $1,697 |
| Laser repair to improve eye fluid flow A laser procedure used to enhance the drainage of fluid within the eye. |
106 | $196 | $2,171 |
| Cataract removal with artificial lens and drainage device insertion Surgical removal of the eye's natural lens followed by the insertion of an artificial lens and a drainage device into the front chamber of the eye. |
79 | $374 | $4,455 |
| Medication injection into the eye A procedure involving the injection of medication directly into the eye. The specific type of medication or clinical purpose is not defined in the provided description. |
63 | $137 | $657 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
38 | $66 | $110 |
| Laser eye fluid drainage tract creation A laser procedure used to create drainage tracts in the iris to help fluid flow out of the eye. |
36 | $248 | $1,153 |
| Retinal imaging (OCT scan) This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye. |
18 | $27 | $200 |
| Eye fluid drainage device insertion A surgical procedure to insert a device into the eye to help drain excess fluid and reduce pressure. |
14 | $786 | $3,300 |
| Complex cataract removal with lens implant A surgical procedure to remove a cataract from the eye and insert an artificial lens to restore vision. |
12 | $327 | $3,125 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.0% high complexity
33.3% medium
61.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$495,755
Total received (2018-2024)
Avg $70,822/year across 7 years
Top 0% in GA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
1,172
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$364,888 (73.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$120,003 (24.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,634 (1.9%)
Scientific / Research
Research funding and grants
$1,231 (0.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$182,691
2023
$86,297
2022
$62,987
2021
$66,710
2020
$44,380
2019
$46,475
2018
$6,215
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Glaukos Corporation
$60,112
Bausch & Lomb Americas Inc.
$58,531
Alcon Vision LLC
$31,831
Sight Sciences, Inc.
$16,018
ABBVIE INC.
$14,845
NEW WORLD MEDICAL,INC.
$498
Harrow Eye, LLC
$355
Microsurgical Technology, Inc.
$116
SUN PHARMACEUTICAL INDUSTRIES INC.
$98
Amgen Inc.
$78
Oyster Point Pharma, Inc.
$71
Johnson & Johnson Surgical Vision, Inc.
$61
Nova Eye, Inc.
$40
ANI Pharmaceuticals, Inc.
$20
RxSight Inc
$18
Top 3 companies account for 82.4% of 2024 payments
All-time payments by company (2018-2024) ›
Glaukos Corporation
$86,993
Bausch & Lomb Americas Inc.
$72,683
Sight Sciences, Inc.
$64,047
Alcon Vision LLC
$56,736
Aerie Pharmaceuticals, Inc.
$45,785
ABBVIE INC.
$42,641
Allergan, Inc.
$39,545
Allergan Inc.
$26,330
AbbVie Inc.
$21,232
Ivantis, Inc
$19,247
GLAUKOS CORPORATION
$9,781
Bausch & Lomb, a division of Bausch Health US, LLC
$4,610
Sun Pharmaceutical Industries Inc.
$970
Alcon Laboratories Inc
$958
NEW WORLD MEDICAL,INC.
$895
Novartis Pharmaceuticals Corporation
$578
Oyster Point Pharma, Inc.
$457
SUN PHARMACEUTICAL INDUSTRIES INC.
$441
Harrow Eye, LLC
$355
EyePoint Pharmaceuticals US, Inc.
$250
Iridex Corporation
$187
Ocular Therapeutix, Inc.
$186
Genentech USA, Inc.
$153
Johnson & Johnson Surgical Vision, Inc.
$150
Microsurgical Technology, Inc.
$116
Amgen Inc.
$78
Thea Pharma Inc.
$62
Akorn Operating Company LLC
$59
Shire North American Group Inc
$55
Horizon Therapeutics plc
$43
Nova Eye, Inc.
$40
Eyevance Pharmaceuticals LLC
$20
ANI Pharmaceuticals, Inc.
$20
Mallinckrodt Hospital Products Inc.
$20
Omeros Corporation
$19
RxSight Inc
$18
Top 3 companies account for 45.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVEFOCUS · ALPHAGAN P · ARGOS · AcrySof · AcrySof IQ PanOptix · AcrySof IQ VIVITY IOL · Ahmed Glaucoma Valve · BROMSITE · BromSite (bromfenac ophthalmic solution) 0.075% · CE-marked KXLA system · CEQUA · COMBIGAN · Centurion · Cequa · Clareon · CyPass · DEXTENZA · DEXYCU · DUREZOL · DURYSTA · ENVISTA ENVY · EYSUVIS · Flarex · HYDRUS Microstent · Hydrus · Hydrus Microstent · IACCESS · ISTENT INJECT W · ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM · Kahook Dual Blade · LOTEMAX · LOTEMAX SM · LUMIGAN · Lucentis · Luxor · MIEBO · NGENUITY · OMNI · OMNI SURGICAL SYSTEM · OMNI Surgical System · OMNI(R) SURGICAL SYSTEM (US) · ORA · OZURDEX · Omidria · PROLENSA · PURIFIED CORTROPHIN GEL · RESTASIS · RESTASIS MULTIDOSE · RXSIGHT CONTACT LENS · Radius · ReSTOR · Rhopressa · Rocklatan · Simbrinza · TEPEZZA · TRAVATAN Z · TYRVAYA · Tecnis IOL · Tecnis Multifocal Family of 1-piece IOLS · Tecnis Simplicity · VABYSMO · VEVYE · VUITY · VYZULTA · XEN · XEN GLAUCOMA TREATMENT SYSTEM · XIIDRA · Zioptan · enVista MX60 IOL · iAccess Precision Blade · iDose · iPRIME Viscodelivery System · iStent Trabecular Micro-Bypass Stent System · iStent Trabecular Micro-Bypass System Model iS3 · iStent infinite Trabecular Micro-Bypass System Model iS3 · iStent inject Trabecular Micro-Bypass Stent System · iStent inject Trabecular Micro-Bypass System · iStent inject Trabecular Micro-Bypass System Model G2-M-IS · iStent inject W · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (74%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in ophthalmology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for ophthalmology in GA.
Geographic Context
Ophthalmologists within 10 mi
263
Per 100K population
24.6
County median income
$91,490
Nearest hospital
SAINT JOSEPH'S HOSPITAL OF ATLANTA, INC
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Yadgarov is a mixed practice specialist, with above-average Medicare volume (top 14% in GA), with speaking/promotional industry engagement in the top 0% of GA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Yadgarov experienced with optic nerve imaging (oct scan)?
Based on Medicare claims data, Dr. Yadgarov performed 772 optic nerve imaging (oct scan) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Yadgarov receive payments from pharmaceutical companies?
Yes. Dr. Yadgarov received a total of $495,755 from 36 companies across 1,172 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Yadgarov's costs compare to other ophthalmologists in Atlanta?
Dr. Yadgarov's average Medicare payment per service is $105. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Yadgarov) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Ophthalmologists in Atlanta
Browse ophthalmologists in Atlanta ranked by procedure volume and transparency data.
Highest volume
Top Ophthalmologists in GA
Ophthalmologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Ophthalmologists in GA
Which GA ophthalmologists receive the most from drug and device companies.
By company
Glaukos Corporation Payments to Doctors
See all physicians who received payments from Glaukos Corporation.
By company
Bausch & Lomb Americas Inc. Payments to Doctors
See all physicians who received payments from Bausch & Lomb Americas Inc.
By company
Sight Sciences, Inc. Payments to Doctors
See all physicians who received payments from Sight Sciences, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology